Translational Science and Therapeutics Division, Fred Hutch
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
Dr. Stanley Lee studies the molecular basis of blood cell development and how its dysregulation can lead to hematologic malignancies such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His research focuses on defining how disease-causing mutations impact the biology of hematopoietic stem and progenitor cells, and how they drive disease progression and response to therapy. The ultimate goal of Dr. Lee’s research is to translate this knowledge into novel treatments for patients with blood-related disorders including leukemia.
Postdoctoral Fellowship, Memorial Sloan Kettering Cancer Center, 2014-2019
PhD, Walter and Eliza Hall Institute of Medical Research, 2012
MSc (Hons), University of Auckland, 2007
BSc (Hons), University of Auckland, 2005
Understanding and targeting altered RNA processing in hematologic malignancies
Epigenetic regulation of normal and malignant hematopoiesis
Identification and development of novel therapeutic approaches to hematologic malignancies
— Dr. Stanley Lee
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email firstname.lastname@example.org or call 206.667.2210